Basic Information
| LncRNA/CircRNA Name | SERHL |
| Synonyms | NA |
| Region | GRCh38_22:42500579-42512560 |
| Ensemble | ENSG00000172250 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR etc. |
| Sample | hepatocellular carcinoma tissues, cell lines (MHCC97L, SMCC-7721, Huh-7, MHCC97H and LO3) |
| Expression Pattern | up-regulated |
| Function Description | We totally identified a set of four lncRNAs(MIR100HG, SERHL, CTD-2574D22.4 and SNHG21) that were significantly correlated with patient's survival. We then measured the expression levels of these four lncRNAs using TCGA data, and found that it was significant. |
| Pubmed ID | 29684484 |
| Year | 2018 |
| Title | Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma. |
External Links
| Links for SERHL | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |